Literature DB >> 15384276

[Hydrodynamic and biochemical adaptation to perfusion pressure profile in isolated hypothermic renal perfusion].

E Lledó García1, C Hernández Fernández, J I Martínez-Salamanca, M Moralejo Gárate, R Cabello Benavente, D Subirá Ríos, J F del Cañizo López.   

Abstract

OBJECTIVES: To evaluate hydrodynamic, biochemical and pathologic consequences of positive forced pressure on hypothermic isolated renal perfusions in comparison to softly progressive administration of perfusion solution. MATERIAL AND
METHOD: 16 hypothermic experimental pig renal perfusion o 180 min completed under constant flow conditions. A vacuum computer-controlled pump was used. A comparison was performed of the results obtained by two groups of organs (forced perfusion pressure -I.B.- and soft perfusion pressure -I.S.).
RESULTS: Even though perfusion flor did not offer significant differences among both groups at the end of the procedure, I.B. group showed medium perfusion pressure and renal vascular resistance values significantly higher. Nitric oxide metabolites concentration was also greater in I.B. group. Finally, these kidneys showed more tubular cell aedema and glomerular shrinkage in comparison to I.S. group.
CONCLUSIONS: Sharp and forced hypothermic perfusion of the isolated kidney don't increase flow perfusion values. Inversely, hydrodynamic and pathologic results are worst in comparison to soft and progressive organ perfusion.

Entities:  

Mesh:

Year:  2004        PMID: 15384276     DOI: 10.1016/s0210-4806(04)73121-6

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  1 in total

1.  Beneficial Effect of Short Pretransplant Period of Hypothermic Pulsatile Perfusion of the Warm-Ischemic Kidney after Cold Storage: Experimental Study.

Authors:  Alberto Lázaro; Blanca Humanes; Juan Carlos Jado; Marina Mojena; María Ángeles González-Nicolás; Juan Francisco Del Cañizo; Alberto Tejedor; Enrique Lledó-García
Journal:  Biomed Res Int       Date:  2016-07-31       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.